Trial will evaluate the safety and effectiveness of AtriCure’s Isolator Synergy Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia
Safety & effectiveness study to evaluate if prophylactic left atrial appendage exclusion reduces occurrence of ischemic stroke or systemic embolism in cardiac surgery patients with elevated risk of stroke and no history of atrial fibrillation
We are Humbled by Our Talented Board and Employees!
Our responsibility to advance Diversity, Equity, and Inclusion is driven by a passionate belief that diverse thinking, skills, and experience bring the best outcome to our work as we innovate products and therapies that improve patients’ lives.
Moderate exercise is known to reduce the risk of Afib, but for middle-aged endurance athletes, it can lead to a 5x increased risk of Afib. To learn more about who this affects, visit https://bit.ly/3PEmYvm#CardioTwitter#afib#Epeeps
Moderate exercise is known to reduce the risk of Afib, but for middle-aged endurance athletes, it can lead to a 5x increased risk of Afib. To learn more about who this affects, visit https://bit.ly/3PEmYvm#CardioTwitter#afib#Epeeps
Join Cardio Thoracic Surgeons, EPs, and Nurses at the 37th EACTS Annual Meeting in Vienna! During EACTS we'll explore AF and HF's close relationship in our Symposium on 5th October. To learn more about AtriCure activities at EACTS, visit https://bit.ly/3rCBDiu#cardiotwitter
Join Cardio Thoracic Surgeons, EPs, and Nurses at the 37th EACTS Annual Meeting in Vienna! During EACTS we'll explore AF and HF's close relationship in our Symposium on 5th October. To learn more about AtriCure activities at EACTS, visit https://bit.ly/3rCBDiu#cardiotwitter
Two is better than one. By approaching Afib with a collaborative approach, individuals with LSPAF in the CONVERGE trial reported better physical and emotional health. For more information and ISI: https://bit.ly/2YxDEyc
Two is better than one. By approaching Afib with a collaborative approach, individuals with LSPAF in the CONVERGE trial reported better physical and emotional health. For more information and ISI: https://bit.ly/2YxDEyc
Cardiovascular diseases, like strokes, are the number 1 cause of death globally. With Afib causing 25% of strokes, it's crucial to treat Afib surgically. Get more data at https://actagainstafib.com#WorldHeartDay
Cardiovascular diseases, like strokes, are the number 1 cause of death globally. With Afib causing 25% of strokes, it's crucial to treat Afib surgically. Get more data at https://actagainstafib.com#WorldHeartDay
Afib is a progressive condition and left untreated can lead to a decrease in quality of life. This condition doesn’t have to be permanent, there is hope. Learn more about Hybrid AF™ Therapy for those with Advanced Afib: hybridaftherapy.com #afibawareness
Afib is a progressive condition and left untreated can lead to a decrease in quality of life. This condition doesn’t have to be permanent, there is hope. Learn more about Hybrid AF™ Therapy for those with Advanced Afib: hybridaftherapy.com #afibawareness
Vass Shantalov is now over a year and a half out from Hybrid AF™ Therapy! Free from Afib, all restrictions, and all medication, he has more energy to do the things he loves.
Vass shares he has gotten back to hiking, giving back, and traveling. And has even served on a mission trip.
Did you miss his full story? Watch now https://bit.ly/3saAUVQ
Vass Shantalov is now over a year and a half out from Hybrid AF™ Therapy! Free from Afib, all restrictions, and all medication, he has more energy to do the things he loves.
Vass shares he has gotten back to hiking, giving back, and traveling. And has even served on a mission trip.
Did you miss his full story? Watch now https://bit.ly/3saAUVQ
Do you have inappropriate sinus tachycardia (IST)? If you've become resistant or intolerant to your medications, you may be a candidate for the HEAL-IST Trial. For participation criteria and study details, visit https://bit.ly/clinical-heal-ist or join our Facebook page: https://bit.ly/3Pn9NAj
Do you have inappropriate sinus tachycardia (IST)? If you've become resistant or intolerant to your medications, you may be a candidate for the HEAL-IST Trial. For participation criteria and study details, visit https://bit.ly/clinical-heal-ist or join our Facebook page: https://bit.ly/3Pn9NAj
Our LeAAPS™ trial is the largest randomized clinical trial in cardiac surgery history.
The trial’s compelling design will assess the safety and effectiveness of surgical LAA exclusion for preventing strokes in cardiac surgery patients that have an elevated risk, but no history of Afib.
To learn more about LeAAPS, visit https://bit.ly/443NaVt
Our LeAAPS™ trial is the largest randomized clinical trial in cardiac surgery history.
The trial’s compelling design will assess the safety and effectiveness of surgical LAA exclusion for preventing strokes in cardiac surgery patients that have an elevated risk, but no history of Afib.
To learn more about LeAAPS, visit https://bit.ly/443NaVt
Today Dr. Lee is kicking off our second Hybrid Ablation Therapies Summit in Arizona with more than 80 attendees. Here we'll cover contemporary Afib patient data, best practices on procedural technique and how to build a sustainable Afib program. Interested to learn more about Hybrid AF™ Therapy? Visit: https://lnkd.in/gxCA4SBP
Today Dr. Lee is kicking off our second Hybrid Ablation Therapies Summit in Arizona with more than 80 attendees. Here we'll cover contemporary Afib patient data, best practices on procedural technique and how to build a sustainable Afib program. Interested to learn more about Hybrid AF™ Therapy? Visit: https://lnkd.in/gxCA4SBP
Of the more than 8 million patients living with Afib in the US, roughly 3.7 million have long-standing persistent Afib. This doesn’t have to be a permanent condition, there is a treatment option. Learn more at https://lnkd.in/gxCA4SBP#afibawareness
Of the more than 8 million patients living with Afib in the US, roughly 3.7 million have long-standing persistent Afib. This doesn’t have to be a permanent condition, there is a treatment option. Learn more at https://lnkd.in/gxCA4SBP#afibawareness
Vass Shantalov is now over a year and a half out from Hybrid AF™ Therapy! Free from Afib, all restrictions, and all medication, he has more energy to do the things he loves.
Vass shares he has gotten back to hiking, giving back, and traveling. And has even served on a mission trip.
Did you miss his full story? Watch now at https://bit.ly/3saAUVQ
Vass Shantalov is now over a year and a half out from Hybrid AF™ Therapy! Free from Afib, all restrictions, and all medication, he has more energy to do the things he loves.
Vass shares he has gotten back to hiking, giving back, and traveling. And has even served on a mission trip.
Did you miss his full story? Watch now at https://bit.ly/3saAUVQ
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
Moderate exercise is known to reduce the risk of Afib, but for middle-aged endurance athletes, it can lead to a 5x increased risk of Afib. To learn more about who this affects, visit https://bit.ly/3PEmYvm #CardioTwitter #afib #Epeeps
Moderate exercise is known to reduce the risk of Afib, but for middle-aged endurance athletes, it can lead to a 5x increased risk of Afib. To learn more about who this affects, visit https://bit.ly/3PEmYvm #CardioTwitter #afib #Epeeps
Join Cardio Thoracic Surgeons, EPs, and Nurses at the 37th EACTS Annual Meeting in Vienna! During EACTS we'll explore AF and HF's close relationship in our Symposium on 5th October. To learn more about AtriCure activities at EACTS, visit https://bit.ly/3rCBDiu #cardiotwitter
Join Cardio Thoracic Surgeons, EPs, and Nurses at the 37th EACTS Annual Meeting in Vienna! During EACTS we'll explore AF and HF's close relationship in our Symposium on 5th October. To learn more about AtriCure activities at EACTS, visit https://bit.ly/3rCBDiu #cardiotwitter
Two is better than one. By approaching Afib with a collaborative approach, individuals with LSPAF in the CONVERGE trial reported better physical and emotional health. For more information and ISI: https://bit.ly/2YxDEyc
Two is better than one. By approaching Afib with a collaborative approach, individuals with LSPAF in the CONVERGE trial reported better physical and emotional health. For more information and ISI: https://bit.ly/2YxDEyc
Cardiovascular diseases, like strokes, are the number 1 cause of death globally. With Afib causing 25% of strokes, it's crucial to treat Afib surgically. Get more data at https://actagainstafib.com #WorldHeartDay
Cardiovascular diseases, like strokes, are the number 1 cause of death globally. With Afib causing 25% of strokes, it's crucial to treat Afib surgically. Get more data at https://actagainstafib.com #WorldHeartDay
social media channels to keep updated on the latest at AtriCure.